Suppr超能文献

不宁腿综合征与睡眠期周期性肢体运动:诊断与治疗

Restless legs syndrome and periodic limb movements during sleep: diagnosis and treatment.

作者信息

Karatas Mehmet

机构信息

Department of Neurology, Baskent University, Medical School, Adana Research Center, 01250, Adana, Turkey.

出版信息

Neurologist. 2007 Sep;13(5):294-301. doi: 10.1097/NRL.0b013e3181422589.

Abstract

BACKGROUND

Restless legs syndrome (RLS) and periodic limb movements during sleep (PLMS) have been known for over 300 years, and they may be present in as many as 25% of patients who have sleep disorders. These patients generally present with insomnia. These disorders often remain undiagnosed for an average of 16 years and patients have seen an average of 13 physicians for their symptoms. Therefore, these disorders merit the attention and interest of the practitioner, so that such patients can be evaluated and treated without delay.

REVIEW SUMMARY

The important features of these disorders are the following: (1) their recognition since 1685, (2) they may comprise up to 25% of all sleep disorders, (3) they require differentiation from many other disorders, and (4) effective treatment is available. Although it is believed that RLS and PLMS are 2 clinical manifestations of the same central nervous system dysfunction, they are generally discussed separately, as different nosological entities.

CONCLUSION

RLS and PLMS are common neurologic disorders and increase in prevalence with aging. These disorders can be disabling conditions, causing sleep disturbance at night and excessive sleepiness during the day. Polysomnography and the suggested immobilization test are used to support the clinical diagnosis of RLS and PLMS. Although levodopa alleviates symptoms, rebound and augmentation occur frequently, limiting the long-term usefulness of this agent. The direct dopamine receptor agonists such as pergolide, pramipexole, ropinirole, and cabergoline have largely replaced levodopa as the most effective treatment for RLS and PLMS.

摘要

背景

不宁腿综合征(RLS)和睡眠期周期性肢体运动(PLMS)已被认知超过300年,在多达25%的睡眠障碍患者中可能存在。这些患者通常表现为失眠。这些病症通常平均16年未被诊断出来,患者因这些症状平均看过13位医生。因此,这些病症值得从业者关注,以便此类患者能及时得到评估和治疗。

综述总结

这些病症的重要特征如下:(1)自1685年起被认识;(2)它们可能占所有睡眠障碍的25%;(3)它们需要与许多其他病症相鉴别;(4)有有效的治疗方法。尽管人们认为RLS和PLMS是同一中枢神经系统功能障碍的两种临床表现,但它们通常作为不同的病种分别进行讨论。

结论

RLS和PLMS是常见的神经系统疾病,患病率随年龄增长而增加。这些病症可能导致残疾,引起夜间睡眠障碍和白天过度嗜睡。多导睡眠图和建议的制动试验用于支持RLS和PLMS的临床诊断。尽管左旋多巴可缓解症状,但频繁出现反跳和症状加重,限制了该药物的长期应用。直接多巴胺受体激动剂,如培高利特、普拉克索、罗匹尼罗和卡麦角林,已在很大程度上取代左旋多巴,成为治疗RLS和PLMS最有效的药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验